The Formedix Clinic

Drop in and catch up on the latest news and standards knowledge. No appointment necessary.

The Formedix Clinic > Study Design

Formedix On Platform Updates: Dec 2018

20 December 2018
by Lesley Gordon About The Author

It's nearly Christmas and from all of us at Formedix, we wish you a very merry one and a happy new year!

Our present to you in our December release is the fully formed Oracle InForm service as well as our continued work to add clarity and make usability improvements.

Read More

Formedix On Platform Updates: Sept 2018

25 September 2018
by Lesley Gordon About The Author

We bring to you the latest Formedix On platform release that provides greater usability through user experience improvements, such as seamless viewing of differences between versions of an asset, viewing assets that have been added or updated in a version of a study or standard and usability improvements for viewing and downloading visualizations and exports.  

Read More

Formedix On Platform Updates: June 2018

18 June 2018
by Lesley Gordon About The Author

The June 2018 update brings some huge improvements to our clinical trial automation platform, Formedix On, giving users complete flexibility and control of their governance processes and change management. In addition, the release history of our products is available as well as various usability improvements.

Read More

Formedix On Platform Updates: February 2018

5 March 2018
by Fiona Hartley About The Author

In late February 2018, we added new functionality our clinical trial automation platform, Formedix On, to further enhance our users' experience. Improved search functionality for trial assets, a new read-only subscription to view your metadata repository, and improved usability for editing objects such as questions on case report forms (CRFs), are among the highlights of the release.

Read More

Paperless Clinical Trials: How Far Away Are We?

11 September 2015
by Fiona Hartley About The Author

As recently as a few years ago, manual data collection in clinical trials was the norm.

Read More

Monday Morning Briefing: the pharma news you need to know

8 September 2014
by Fiona Hartley About The Author

It's the first Monday Morning Briefing since Labor Day, so today's news has a distinctly darker-than-normal hue. Here are the breaking pharma stories you need to know about this morning.

Read More

Fast and Flexible Standards with CDISC

26 May 2014
by Jim Garety About The Author

Case report forms (CRFs) are not exempt from the watchful eye of standards; they collect data from clinical research studies in a structured fashion. Their credibility exists primarily because they are regulated by peer reviewed standards.

Read More

Tracking the evolution of CDISC SDTM

21 February 2014
by Ed Chappell About The Author

While sitting in Reykjavik airport recently, I found myself pondering the growth of the SDTM general observation classes over the years. At Formedix, we create machine readable templates for each version of the SDTM standard, which, over time, has provided a series of snapshots of the SDTM standard. Being unable to understand Icelandic television, I decided to extract some basic statistics from the SDTM templates and analyze exactly how they had changed from version to version. The results are rather surprising...

Read More

Rave? OpenClinica? Migrating studies between EDCs isn't so tough...

18 December 2013
by Greg Blincow About The Author

Have you ever found yourself looking for a simple way to transfer your study metadata to an EDC system? This can prove tricky as different EDC systems utilize different import mechanisms, and use a variety of formats, as well as having their own proprietary metadata. To combat this issue, we have created a suite of ‘Transform for EDC’ products which work in conjunction with our data acquisition design tool.

Read More

'CRO industry revenue expected to double'...will you be part of it?

21 November 2013
by Fiona Hartley About The Author

We all know that the end-to-end clinical trial process is becoming more complex and more heavily regulated, week on week, by authorities such as the FDA. We regularly learn of customers and industry professionals who are outsourcing to Contract Research Organizations (CROs) to undertake their studies, and it is becoming increasingly more popular - around 40% of drug development is currently outsourced.

Read More